215% return in 2 years: Buy this pharma stocks before Q1FY25 results – Check target price by Anil Singhvi ,Stocks News, Business News

Zydus Lifesciences Share Price Target: The result season for the first quarter of the financial year 2024-25 is about to begin. Ahead of that, market wizard Anil Singhvi is of the view that the performance of pharma sector companies is expected to be good. Considering this, there is an opportunity for positional investors to earn money and Singhvi has advised investors to buy shares of Zydus Lifesciences before the company announces its Q1FY25 results. 
Zydus Lifesciences Share…
Read More…

Source: https://www.zeebiz.com/markets/stocks/news-zydus-lifesciences-share-price-target-nse-bse-by-anil-singhvi-pharma-stock-to-buy-q1-results-zyduslife-299916/amp